Case Report
Published on 02 Jul 2025
Case Report: Immune checkpoint inhibitor exhibits dual benefits for a refractory lymphoma patient with disseminated mucormycosis
in Infectious Diseases: Pathogenesis and Therapy
Frontiers in Medicine
doi 10.3389/fmed.2025.1608828
- 1,961 views